Correction to: The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
An amendment to this paper has been published and can be accessed via the original article.
Main Authors: | Mathieu Blot, Jean-Baptiste Bour, Jean Pierre Quenot, Abderrahmane Bourredjem, Maxime Nguyen, Julien Guy, Serge Monier, Marjolaine Georges, Audrey Large, Auguste Dargent, Alexandre Guilhem, Suzanne Mouries-Martin, Jeremy Barben, Belaid Bouhemad, Pierre‑Emmanuel Charles, Pascal Chavanet, Christine Binquet, Lionel Piroth, for the LYMPHONIE Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Journal of Translational Medicine |
Online Access: | https://doi.org/10.1186/s12967-021-02746-0 |
Similar Items
-
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
by: Mathieu Blot, et al.
Published: (2020-12-01) -
Specific Features of the Coagulopathy Signature in Severe COVID-19 Pneumonia
by: Mathieu Blot, et al.
Published: (2021-08-01) -
Septic shock, noradrenaline requirements and alpha-2 agonists: Fishing in the right pond?
by: Auguste Dargent, et al.
Published: (2021-02-01) -
High plasma concentration of non-esterified polyunsaturated fatty acids is a specific feature of severe COVID-19 pneumonia
by: Maxime Nguyen, et al.
Published: (2021-05-01) -
CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS
by: Mathieu Blot, et al.
Published: (2020-11-01)